SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

BACKGROUND & AIMS: Liver enzyme abnormalities are common in patients with coronavirus disease 2019 (COVID-19). Whether or not severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to liver damage per se remains unknown. Herein, we reported the clinical characteristics a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yijin, Liu, Shuhong, Liu, Hongyang, Li, Wei, Lin, Fang, Jiang, Lina, Li, Xi, Xu, Pengfei, Zhang, Lixin, Zhao, Lihua, Cao, Yun, Kang, Jiarui, Yang, Jianfa, Li, Ling, Liu, Xiaoyan, Li, Yan, Nie, Ruifang, Mu, Jinsong, Lu, Fengmin, Zhao, Shousong, Lu, Jiangyang, Zhao, Jingmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211738/
https://www.ncbi.nlm.nih.gov/pubmed/32437830
http://dx.doi.org/10.1016/j.jhep.2020.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211738/
https://www.ncbi.nlm.nih.gov/pubmed/32437830
http://dx.doi.org/10.1016/j.jhep.2020.05.002

Ejemplares similares